Skip to main content

Advertisement

Log in

Impact of Islet Transplantation on Diabetes Complications and Quality of Life

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Insulin represents a life-saving therapy for patients with type 1 diabetes but, despite appropriate treatment, it prevents only partially long-term diabetic complications, while generating fatal hypoglycemic episodes. Islet transplantation gained attention because of its safety, effectiveness, and minimal invasiveness; however it remains a procedure reserved for a selected group of patients. The introduction of the Edmonton Protocol in 2000, based on a newly designed steroid-free immunosuppressive protocol, revamped the course of islet transplantation. The main goal of islet transplantation remains insulin independence, although the effect of islet transplantation can be more comprehensively evaluated in terms of frequency of hypoglycemic episodes and impact on diabetic complications and quality of life. Islet transplantation was shown to have positive consequences on cardiovascular, renal, neurologic, and ocular diabetic complications. The proof of concept for cellular replacement therapy in diabetes has been established with islet transplantation, it only needs to be improved and rendered widely available.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Bloomgarden ZT. Diabetes complications. Diabetes Care. 2004;27:1506–14.

    Article  PubMed  Google Scholar 

  2. Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia. 1973;9:486–91.

    Article  PubMed  CAS  Google Scholar 

  3. Najarian JS, Sutherland DE, Matas AJ, Steffes MW, Simmons RL, Goetz FC. Human islet transplantation: a preliminary report. Transplant Proc. 1977;9:233–6.

    PubMed  CAS  Google Scholar 

  4. Largiader F, Kolb E, Binswanger U, Illig R. Successful allotransplantation of an island of Langerhans. Schweiz Med Wochenschr. 1979;109:1733–6.

    PubMed  CAS  Google Scholar 

  5. Scharp DW, Lacy PE, Santiago JV, et al. Insulin independence after islet transplantation into type I diabetic patient. Diabetes. 1990;39:515–8.

    Article  PubMed  CAS  Google Scholar 

  6. Pileggi A, Ricordi C, Kenyon NS, et al. Twenty years of clinical islet transplantation at the Diabetes Research Institute—University of Miami. Clin Transpl. 2004:177–204.

  7. Pyzdrowski KL, Kendall DM, Halter JB, Nakhleh RE, Sutherland DE, Robertson RP. Preserved insulin secretion and insulin independence in recipients of islet autografts. N Engl J Med. 1992;327:220–6.

    Article  PubMed  CAS  Google Scholar 

  8. Tzakis AG, Ricordi C, Alejandro R, et al. Pancreatic islet transplantation after upper abdominal exenteration and liver replacement. Lancet. 1990;336:402–5.

    Article  PubMed  CAS  Google Scholar 

  9. Ricordi C, Tzakis AG, Carroll PB, et al. Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation. 1992;53:407–14.

    Article  PubMed  CAS  Google Scholar 

  10. Brendel M. International islet transplant registry newsletter No.9. Volume 8. Number 1. 2001.

  11. Oberholzer J, Triponez F, Mage R, et al. Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. Transplantation. 2000;69:1115–23.

    Article  PubMed  CAS  Google Scholar 

  12. Oberholzer J, Toso C, Triponez F, et al. Human islet allotransplantation with Basiliximab in type I diabetic patients with end-stage renal failure. Transplant Proc. 2002;34:823–5.

    Article  PubMed  CAS  Google Scholar 

  13. Benhamou PY, Oberholzer J, Toso C, et al. Human islet transplantation network for the treatment of Type I diabetes: first data from the Swiss-French GRAGIL consortium (1999–2000). Groupe de Recherche Rhin Rhjne Alpes Geneve pour la transplantation d’Ilots de Langerhans. Diabetologia. 2001;44:859–64.

    Article  PubMed  CAS  Google Scholar 

  14. Hering BJ, Bretzel RG, Hopt UT, et al. New protocol toward prevention of early human islet allograft failure. Transplant Proc. 1994;26:570–1.

    PubMed  CAS  Google Scholar 

  15. Bretzel RG, Brandhorst D, Brandhorst H, et al. Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management. J Mol Med. 1999;77:140–3.

    Article  PubMed  CAS  Google Scholar 

  16. Secchi A, Socci C, Maffi P, et al. Islet transplantation in IDDM patients. Diabetologia. 1997;40:225–31.

    Article  PubMed  CAS  Google Scholar 

  17. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343:230–8.

    Article  PubMed  CAS  Google Scholar 

  18. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355:1318–30.

    Article  PubMed  CAS  Google Scholar 

  19. Ryan EA, Paty BW, Senior PA, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54:2060–9.

    Article  PubMed  CAS  Google Scholar 

  20. Lee TC, Barshes NR, Brunicardi FC, et al. Procurement of the human pancreas for pancreatic islet transplantation. Transplantation. 2004;78:481–3.

    Article  PubMed  Google Scholar 

  21. Venturini M, Angeli E, Maffi P, et al. Technique, complications, and therapeutic efficacy of percutaneous transplantation of human pancreatic islet cells in type 1 diabetes: the role of US. Radiology. 2005;234:617–24.

    Article  PubMed  Google Scholar 

  22. Robertson RP. Islet transplantation a decade later and strategies for filling a half-full glass. Diabetes. 2010;59:1285–91.

    Article  PubMed  CAS  Google Scholar 

  23. Hafiz MM, Faradji RN, Froud T, et al. Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation. Transplantation. 2005;80:1718–28.

    Article  PubMed  CAS  Google Scholar 

  24. Lakey JR, Mirbolooki M, Shapiro AM. Current status of clinical islet cell transplantation. Methods Mol Biol. 2006;333:47–104.

    PubMed  Google Scholar 

  25. Berney T, Toso C. Monitoring of the islet graft. Diabetes Metab. 2006;32:503–12.

    Article  PubMed  CAS  Google Scholar 

  26. Vantyghem MC, Kerr-Conte J, Arnalsteen L, et al. Primary graft function, metabolic control, and graft survival after islet transplantation. Diabetes Care. 2009;32:1473–8.

    Article  PubMed  CAS  Google Scholar 

  27. Naftanel MA, Harlan DM. Pancreatic islet transplantation. PLoS Med. 2004;1:e58; quiz e75.

  28. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–86.

  29. • Fiorina P, Shapiro AM, Ricordi C, Secchi A. The clinical impact of islet transplantation. Am J Transplant. 2008;8:1990–7. This work comprehensively reviews the state of the art of islet transplantation, immunosuppression, outcomes, and their impact on patients’ survival and long-term diabetic complications.

    Article  PubMed  CAS  Google Scholar 

  30. Hering BJ, Browatzki CC, Schultz A, Bretzel RG, Federlin KF. Clinical islet transplantation–registry report, accomplishments in the past and future research needs. Cell Transplant. 1993;2:269–82. discussion 83–305.

    PubMed  CAS  Google Scholar 

  31. Gaston RS, Basadonna G, Cosio FG, et al. Transplantation in the diabetic patient with advanced chronic kidney disease: a task force report. Am J Kidney Dis. 2004;44:529–42.

    PubMed  Google Scholar 

  32. Robertson RP. Update on transplanting beta cells for reversing type 1 diabetes. Endocrinol Metab Clin North Am. 2010;39:655–67.

    Article  PubMed  CAS  Google Scholar 

  33. Maffi P, Bertuzzi F, De Taddeo F, et al. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy. Diabetes Care. 2007;30:1150–5.

    Article  PubMed  CAS  Google Scholar 

  34. Robertson RP. Islet transplantation as a treatment for diabetes—a work in progress. N Engl J Med. 2004;350:694–705.

    Article  PubMed  CAS  Google Scholar 

  35. Nir T, Melton DA, Dor Y. Recovery from diabetes in mice by beta cell regeneration. J Clin Invest. 2007;117:2553–61.

    Article  PubMed  CAS  Google Scholar 

  36. Brunicardi FC, Atiya A, Stock P, et al. Clinical islet transplantation experience of the University of California Islet Transplant Consortium. Surgery. 1995;118:967–71. discussion 71–2.

    Article  PubMed  CAS  Google Scholar 

  37. Goss JA, Goodpastor SE, Brunicardi FC, et al. Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center. Transplantation. 2004;77:462–6.

    Article  PubMed  Google Scholar 

  38. Shapiro AM, Ricordi C, Hering B. Edmonton’s islet success has indeed been replicated elsewhere. Lancet. 2003;362:1242.

    Article  PubMed  Google Scholar 

  39. Toso C, Baertschiger R, Morel P, et al. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol. Am J Transplant: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006;6:1049–58.

    CAS  Google Scholar 

  40. Gerber PA, Pavlicek V, Demartines N, et al. Simultaneous islet-kidney vs pancreas-kidney transplantation in type 1 diabetes mellitus: a 5 year single centre follow-up. Diabetologia. 2008;51:110–9.

    Article  PubMed  CAS  Google Scholar 

  41. Froud T, Ricordi C, Baidal DA, et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2005;5:2037–46.

    Google Scholar 

  42. Hering BJ, Kandaswamy R, Harmon JV, et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2004;4:390–401.

    CAS  Google Scholar 

  43. Bellin MD, Kandaswamy R, Parkey J, et al. Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes. Am J Transplant. 2008;8:2463–70.

    Article  PubMed  CAS  Google Scholar 

  44. Gangemi A, Salehi P, Hatipoglu B, et al. Islet transplantation for brittle type 1 diabetes: the UIC protocol. Am J Transplant. 2008;8:1250–61.

    Article  PubMed  CAS  Google Scholar 

  45. Skyler JS, Greenbaum CJ, Lachin JM, et al. Type 1 Diabetes TrialNet–an international collaborative clinical trials network. Ann N Y Acad Sci. 2008;1150:14–24.

    Article  PubMed  Google Scholar 

  46. Oberholzer J, Kinzer K, Fiorina P. The anti-LFA-1 trial in islet transplantation. Am J Transplant. 2010;10:1725–6.

    Article  PubMed  CAS  Google Scholar 

  47. •• Alejandro R, Barton FB, Hering BJ, Wease S. 2008 Update from the Collaborative Islet Transplant Registry. Transplantation 2008;86:1783–8. This paper summarizes the most recent update from the CITR and represents the most complete collection of information on islet transplantation.

    Article  PubMed  Google Scholar 

  48. Davalli AM, Maffi P, Socci C, et al. Insights from a successful case of intrahepatic islet transplantation into a type 1 diabetic patient. J Clin Endocrinol Metab. 2000;85:3847–52.

    Article  PubMed  CAS  Google Scholar 

  49. Berney T, Ferrari-Lacraz S, Buhler L, et al. Long-term insulin-independence after allogeneic islet transplantation for type 1 diabetes: over the 10-year mark. Am J Transplant. 2009;9:419–23.

    Article  PubMed  CAS  Google Scholar 

  50. Alejandro R, Lehmann R, Ricordi C, et al. Long-term function (6 years) of islet allografts in type 1 diabetes. Diabetes. 1997;46:1983–9.

    Article  PubMed  CAS  Google Scholar 

  51. Luzi L, Perseghin G, Brendel MD, et al. Metabolic effects of restoring partial beta-cell function after islet allotransplantation in type 1 diabetic patients. Diabetes. 2001;50:277–82.

    Article  PubMed  CAS  Google Scholar 

  52. Rickels MR, Schutta MH, Markmann JF, Barker CF, Naji A, Teff KL. {beta}-Cell function following human islet transplantation for type 1 diabetes. Diabetes. 2005;54:100–6.

    Article  PubMed  CAS  Google Scholar 

  53. Poggioli R, Faradji RN, Ponte G, et al. Quality of life after islet transplantation. Am J Transplant: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 2006;6:371–8.

    CAS  Google Scholar 

  54. Geiger MC, Ferreira JV, Hafiz MM, et al. Evaluation of metabolic control using a continuous subcutaneous glucose monitoring system in patients with type 1 diabetes mellitus who achieved insulin independence after islet cell transplantation. Cell Transplant. 2005;14:77–84.

    Article  PubMed  Google Scholar 

  55. Ryan EA, Shandro T, Green K, et al. Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes. 2004;53:955–62.

    Article  PubMed  CAS  Google Scholar 

  56. Poggioli R, Faradji RN, Ponte G, et al. Quality of life after islet transplantation. Am J Transplant. 2006;6:371–8.

    Article  PubMed  CAS  Google Scholar 

  57. Barshes NR, Vanatta JM, Mote A, et al. Health-related quality of life after pancreatic islet transplantation: a longitudinal study. Transplantation. 2005;79:1727–30.

    Article  PubMed  Google Scholar 

  58. Johnson JA, Kotovych M, Ryan EA, Shapiro AM. Reduced fear of hypoglycemia in successful islet transplantation. Diabetes Care. 2004;27:624–5.

    Article  PubMed  Google Scholar 

  59. Endicott J, Nee J, Harrison W, Blumenthal R. Quality of life enjoyment and satisfaction questionnaire: a new measure. Psychopharmacol Bull. 1993;29:321–6.

    PubMed  CAS  Google Scholar 

  60. Teran-Escandon D, Teran-Ortiz L, Ormsby-Jenkins C, Evia-Viscarra ML, White DJ, Valdes-Gonzalez-Salas R. Psychosocial aspects of xenotransplantation: survey in adolescent recipients of porcine islet cells. Transplant Proc. 2005;37:521–4.

    Article  PubMed  CAS  Google Scholar 

  61. Reliability and validity of a diabetes quality-of-life measure for the diabetes control and complications trial (DCCT). The DCCT Research Group. Diabetes Care 1988;11:725–32.

  62. Toso C, Shapiro AM, Bowker S, et al. Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome. Transplantation. 2007;84:664–6.

    Article  PubMed  Google Scholar 

  63. Cure P, Pileggi A, Froud T, et al. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation. Transplantation. 2008;85:801–12.

    Article  PubMed  CAS  Google Scholar 

  64. Tharavanij T, Betancourt A, Messinger S, et al. Improved long-term health-related quality of life after islet transplantation. Transplantation. 2008;86:1161–7.

    Article  PubMed  Google Scholar 

  65. Melton 3rd LJ, Macken KM, Palumbo PJ, Elveback LR. Incidence and prevalence of clinical peripheral vascular disease in a population-based cohort of diabetic patients. Diabetes Care. 1980;3:650–4.

    Article  PubMed  Google Scholar 

  66. Fiorina P, Gremizzi C, Maffi P, et al. Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care. 2005;28:1358–65.

    Article  PubMed  Google Scholar 

  67. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676–85.

    Article  PubMed  CAS  Google Scholar 

  68. Fiorina P, Folli F, D’Angelo A, et al. Normalization of multiple hemostatic abnormalities in uremic type 1 diabetic patients after kidney-pancreas transplantation. Diabetes. 2004;53:2291–300.

    Article  PubMed  CAS  Google Scholar 

  69. Fiorina P, Folli F, Zerbini G, et al. Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol. 2003;14:2150–8.

    Article  PubMed  Google Scholar 

  70. Fiorina P, Venturini M, Folli F, et al. Natural history of kidney graft survival, hypertrophy, and vascular function in end-stage renal disease type 1 diabetic kidney-transplanted patients: beneficial impact of pancreas and successful islet cotransplantation. Diabetes Care. 2005;28:1303–10.

    Article  PubMed  Google Scholar 

  71. Fung MA, Warnock GL, Ao Z, et al. The effect of medical therapy and islet cell transplantation on diabetic nephropathy: an interim report. Transplantation. 2007;84:17–22.

    Article  PubMed  Google Scholar 

  72. Leitao CB, Cure P, Messinger S, et al. Stable renal function after islet transplantation: importance of patient selection and aggressive clinical management. Transplantation. 2009;87:681–8.

    Article  PubMed  Google Scholar 

  73. Senior PA, Zeman M, Paty BW, Ryan EA, Shapiro AM. Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant. 2007;7:91–8.

    Article  PubMed  CAS  Google Scholar 

  74. Vinik AI, Park TS, Stansberry KB, Pittenger GL. Diabetic neuropathies. Diabetologia. 2000;43:957–73.

    Article  PubMed  CAS  Google Scholar 

  75. Lee TC, Barshes NR, O’Mahony CA, et al. The effect of pancreatic islet transplantation on progression of diabetic retinopathy and neuropathy. Transplant Proc. 2005;37:2263–5.

    Article  PubMed  CAS  Google Scholar 

  76. Del Carro U, Fiorina P, Amadio S, et al. Evaluation of polyneuropathy markers in type 1 diabetic kidney transplant patients and effects of islet transplantation: neurophysiological and skin biopsy longitudinal analysis. Diabetes Care. 2007;30:3063–9.

    Article  PubMed  Google Scholar 

  77. McCall AL. Diabetes mellitus and the central nervous system. Int Rev Neurobiol. 2002;51:415–53.

    Article  PubMed  CAS  Google Scholar 

  78. Franceschi M, Cecchetto R, Minicucci F, Smizne S, Baio G, Canal N. Cognitive processes in insulin-dependent diabetes. Diabetes Care. 1984;7:228–31.

    Article  PubMed  CAS  Google Scholar 

  79. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–36.

    Article  PubMed  Google Scholar 

  80. Venturini M, Fiorina P, Maffi P, et al. Early increase of retinal arterial and venous blood flow velocities at color Doppler imaging in brittle type 1 diabetes after islet transplant alone. Transplantation. 2006;81:1274–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Paolo Fiorina is the recipient of a JDRF and ASN Career Development Award and of a MIUR grant: (“Staminali” RF-FSR-2008-1213704).

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paolo Fiorina.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bassi, R., Fiorina, P. Impact of Islet Transplantation on Diabetes Complications and Quality of Life. Curr Diab Rep 11, 355–363 (2011). https://doi.org/10.1007/s11892-011-0211-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-011-0211-1

Keywords

Navigation